Search research articles
Contact Us
Filters
Showing results (111-120 of 118) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 118 results.
Molecular Oncology
|
August 5, 2020
Towards a cancer mission in Horizon Europe: recommendations
Anton Berns, Ulrik Ringborg, Julio E Celis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 28, 2014
Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative
Jan Bogaerts, Matthew R Sydes, Nicola Keat, et al.
The Lancet. Oncology
|
October 1, 2016
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
Brigitta G Baumert, Monika E Hegi, Martin J van den Bent, et al.
Molecular Oncology
|
September 13, 2021
The Porto European Cancer Research Summit 2021
Ulrik Ringborg, Anton Berns, Julio E Celis, et al.
Cancer Treatment Reviews
|
August 11, 2025
How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancers
Silvia Stacchiotti, Pan Pantziarka, Hugh Leonard, et al.
JAMA Oncology
|
December 18, 2025
Enhancing Clinical Cancer Research Through Sharing of Data and Biospecimens
Hans Wildiers, Virginie Adam, Seamus O'Reilly, et al.
ESMO Open
|
August 30, 2017
The European Cancer Patient's Bill of Rights, update and implementation 2016
Mark Lawler, Ian Banks, Kate Law, et al.
Nature Reviews. Clinical Oncology
|
October 12, 2016
Imaging biomarker roadmap for cancer studies
James P B O'Connor, Eric O Aboagye, Judith E Adams, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 118) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 118 results.
Molecular Oncology
|
August 5, 2020
Towards a cancer mission in Horizon Europe: recommendations
Anton Berns, Ulrik Ringborg, Julio E Celis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 28, 2014
Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative
Jan Bogaerts, Matthew R Sydes, Nicola Keat, et al.
The Lancet. Oncology
|
October 1, 2016
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
Brigitta G Baumert, Monika E Hegi, Martin J van den Bent, et al.
Molecular Oncology
|
September 13, 2021
The Porto European Cancer Research Summit 2021
Ulrik Ringborg, Anton Berns, Julio E Celis, et al.
Cancer Treatment Reviews
|
August 11, 2025
How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancers
Silvia Stacchiotti, Pan Pantziarka, Hugh Leonard, et al.
JAMA Oncology
|
December 18, 2025
Enhancing Clinical Cancer Research Through Sharing of Data and Biospecimens
Hans Wildiers, Virginie Adam, Seamus O'Reilly, et al.
ESMO Open
|
August 30, 2017
The European Cancer Patient's Bill of Rights, update and implementation 2016
Mark Lawler, Ian Banks, Kate Law, et al.
Nature Reviews. Clinical Oncology
|
October 12, 2016
Imaging biomarker roadmap for cancer studies
James P B O'Connor, Eric O Aboagye, Judith E Adams, et al.
Page
of 12